Super-shift EMSA with a well-characterized monoclonal antibody against U2AF65[37] consistently produced a super-shifted H3 band in all human extracts tested that were known to express U2AF65 by Western blot analysis (RKO and tumor tissue cytoplasmic and nuclear extracts are shown in Figure4). This evidence concerns the gene U2AF2 and neoplasm.